BioAmber Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's product sales were $367,000 against $351,000 a year ago. Operating loss was $8,460,000 against $7,501,000 a year ago.

Loss before income taxes was $8,935,000 against $19,927,000 a year ago. Net loss attributable to the company shareholders was $8,258,000 or $0.38 per basic share against $19,911,000 or $1.07 per basic share a year ago. Net cash used in operating activities was $5,923,000 against $4,867,000 a year ago.

Acquisition of property and equipment was $29,055,000 against $12,731,000 a year ago. Adjusted net loss attributable to the company shareholders was $8,578,000 or $0.39 per basic share against $8,311,000 or $0.45 per basic share a year ago.